Track the Astrana Health, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 9 September 2026 (Retenue fiscale). Among the most active insiders: Basho Chandan. The full history is accessible without an account.
97
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€11m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Astrana Health, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
42Σ signal
Buys n/a€11m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,325 of 29,064 companies
17.1
score / 100
Value
24
Quality
10
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn0.0%
Net mgn-4.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
21,334 shares@ US$23.2420.6% of flowCommon StockSEC:0001104659-26-009940:0
25 of 97 declarations
Acerca de Astrana Health, Inc.
Astrana Health, Inc. es una empresa que cotiza en el mercado XNAS. Se enfoca en el sector de la salud, proporcionando soluciones innovadoras para mejorar el bienestar del paciente.